Ascorbic Acid Promotes KIR Demethylation during Early NK Cell Differentiation
- PMID: 32759296
- PMCID: PMC7484163
- DOI: 10.4049/jimmunol.2000212
Ascorbic Acid Promotes KIR Demethylation during Early NK Cell Differentiation
Abstract
Variegated expression of killer Ig-like receptors (KIR) in human NK cells is a stochastic process exclusive to subsets of mature NK cells and CD8+ T cells. Allele-specific KIR expression is maintained by DNA methylation within the proximal promoter regions. Because KIR genes are densely methylated in NK cell progenitors, there is an implied stage of human NK cell development in which DNA demethylation takes place to allow for active transcription. When and how this process occurs is unknown. In this study, we show that KIR proximal promoters are densely methylated in less mature CD56bright NK cells and are progressively demethylated in CD56dim NK cells as they mature and acquire KIR. We hypothesized that ten-eleven translocation (TET) enzymes, which oxidize 5mC on DNA could mediate KIR promoter demethylation. The catalytic efficiency of TET enzymes is known to be enhanced by ascorbic acid. We found that the addition of ascorbic acid to ex vivo culture of sorted CD56bright NK cells increased the frequency of KIR expression in a dose-dependent manner and facilitated demethylation of proximal promoters. A marked enrichment of the transcription factor Runx3 as well as TET2 and TET3 was observed within proximal KIR promoters in CD56bright NK cells cultured with ascorbic acid. Additionally, overexpression of TET3 and Runx3 promoted KIR expression in CD56bright NK cells and NK-92 cells. Our results show that KIR promoter demethylation can be induced in CD56bright, and this process is facilitated by ascorbic acid.
Copyright © 2020 by The American Association of Immunologists, Inc.
Conflict of interest statement
Conflict of interest: F.C. consults for Fate Therapeutics and has received research funds from this relationship. J.S.M. serves on the Scientific Advisory Board (SAB) and consults for GT BioPharma and Fate Therapeutics. He has received research funds from these relationships. J.S.M. also serves on the SAB for CytoSen and Onkimmune. None of these companies had a role in funding this research. All conflicts are managed according to institutional policies.
Figures
Similar articles
-
New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.Front Immunol. 2018 Oct 15;9:2360. doi: 10.3389/fimmu.2018.02360. eCollection 2018. Front Immunol. 2018. PMID: 30374356 Free PMC article.
-
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.J Immunol. 2007 Apr 15;178(8):4947-55. doi: 10.4049/jimmunol.178.8.4947. J Immunol. 2007. PMID: 17404276
-
Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.J Immunol. 2009 May 15;182(10):6426-34. doi: 10.4049/jimmunol.0804224. J Immunol. 2009. PMID: 19414796 Free PMC article.
-
Human NK Cell Development: One Road or Many?Front Immunol. 2019 Aug 29;10:2078. doi: 10.3389/fimmu.2019.02078. eCollection 2019. Front Immunol. 2019. PMID: 31555287 Free PMC article. Review.
-
The biology of human natural killer-cell subsets.Trends Immunol. 2001 Nov;22(11):633-40. doi: 10.1016/s1471-4906(01)02060-9. Trends Immunol. 2001. PMID: 11698225 Review.
Cited by
-
Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis.Stem Cell Res Ther. 2023 Oct 15;14(1):295. doi: 10.1186/s13287-023-03461-x. Stem Cell Res Ther. 2023. PMID: 37840146 Free PMC article.
-
Effects of epigenetic therapy on natural killer cell function and development in hematologic malignancy.J Leukoc Biol. 2023 May 2;113(5):518-524. doi: 10.1093/jleuko/qiad026. J Leukoc Biol. 2023. PMID: 36860165 Free PMC article. Review.
-
NK cell education: Physiological and pathological influences.Front Immunol. 2023 Jan 20;14:1087155. doi: 10.3389/fimmu.2023.1087155. eCollection 2023. Front Immunol. 2023. PMID: 36742337 Free PMC article. Review.
-
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.Nat Commun. 2023 Feb 3;14(1):588. doi: 10.1038/s41467-023-36193-w. Nat Commun. 2023. PMID: 36737440 Free PMC article.
-
Repurposing Vitamin C for Cancer Treatment: Focus on Targeting the Tumor Microenvironment.Cancers (Basel). 2022 May 25;14(11):2608. doi: 10.3390/cancers14112608. Cancers (Basel). 2022. PMID: 35681589 Free PMC article. Review.
References
-
- Kärre K, Lunggren HG, Piontek G, and Kiessling R. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 319: 675–678. - PubMed
-
- Trowsdale J. 2001. Genetic and functional relationships between MHC and NK receptor genes. Immunity. 15: 363–374. - PubMed
-
- Braud VM, Allan DS, O’Callaghan CA, Söderström K,, D’Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391: 795–799. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
